6
Views
10
CrossRef citations to date
0
Altmetric
Cell Growth and Development

C-Terminal Truncated Forms of Met, the Hepatocyte Growth Factor Receptor

, , , , &
Pages 5954-5962 | Received 04 Apr 1991, Accepted 10 Sep 1991, Published online: 31 Mar 2023

REFERENCES

  • Basu, Α., Μ. Raghunath, S. Bishayee, and M. Das. 1989. Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor form that binds to EGF: role for interreceptor interaction in kinase regulation. Mol. Cell. Biol. 9:671-677.
  • Beguin, Y., H. A. Huebers, B. Josephson, and C. A. Finch. 1988. Transferrin receptors in rat plasma. Proc. Natl. Acad. Sci. USA 85:637-640.
  • Bottaro, D. P., J. S. Rubin, D. L. Faletto, A. M.-L. Chan, Τ. Ε. Kmiecik, G. F. Vande Woude, and S. A. Aaronson. 1991. Identification of the HGF receptor as the c-MET proto-onco-gene product. Science 251:802-804.
  • Cooper, C. S., M. Park, D. Blair, M. A. Tainsky, K. Huebner, C. M. Croce, and G. F. Vande Woude. 1984. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature (London) 311:29-33.
  • Dean, M., M. Park, M. M. Le Beau, T. S. Robins, M. O. Diaz, J. D. Rowley, D. G. Blair, and G. F. Vande Woude. 1985. The human met oncogene is related to the tyrosine kinase oncogenes. Nature (London) 318:385-388.
  • Decker, S. J. 1989. Epidermal growth factor-induced truncation of the epidermal growth factor receptor. J. Biol. Chem. 264:17641-17644.
  • DiStefano, P., and Ε. Μ. Johnson. 1988. Identification of a truncated form of the nerve growth factor receptor. Proc. Natl. Acad. Sci. USA 85:270-274.
  • Downing, J. R., M. F. Roussel, and C. J. Sherr. 1989. Ligand and protein kinase C downmodulate the colony-stimulating factor 1 receptor by independent mechanisms. Mol. Cell. Biol. 9:2890-2896.
  • Ey, P. L., S. J. Prowse, and C. R. Jenkin. 1978. Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-Sepharose. Immunochemistry 15:429-436.
  • Fenacini, R., P. Longati, L. Naldini, E. Vigna, and P. M. Comoglio. Identification of the major autophosphorylation site of the Met/HGF receptor tyrosine kinase. J. Biol. Chem., in press.
  • Fukunaga, R., Y. Seto, S. Mizushima, and S. Nagata. 1990. Three different mRNAs encoding human granulocyte colony-stimulating factor receptor. Proc. Natl. Acad. Sci. USA 87:8702-8706.
  • Gandino, L., M. F. Di Renzo, S. Giordano, F. Bussolino, and P. M. Comoglio. 1990. Protein kinase-c activation inhibits tyrosine phosphorylation of the c-met protein. Oncogene 5:721-725.
  • Gatanaga, T., C. Hwang, W. Kohr, F. Cappuccini, J. A. Lucci, E. W. B. Jeffes, J. Tomich, R. S. Yamamoto, and G. A. Granger. 1990. Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients. Proc. Natl. Acad. Sci. USA 87:8781-8784.
  • Giordano, S., M. F. Di Renzo, R. Ferracini, L. Chiadò-Piat, and P. M. Comoglio. 1988. pl45, a protein with associated tyrosine kinase activity in a human gastric carcinoma cell line. Mol. Cell. Biol. 8:3510-3517.
  • Giordano, S., M. F. Di Renzo, R. Narsimhan, C. S. Cooper, C. Rosa, and P. M. Comoglio. 1989. Biosynthesis of the protein encoded by the c-met protooncogene. Oncogene 4:1383-1388.
  • Giordano, S., C. Ponzetto, M. F. Di Renzo, C. S. Cooper, and P. M. Comoglio. 1989. Tyrosine kinase receptor indistinguishable from the c-met protein. Nature (London) 339:155-156.
  • Giordano, S. et al. Unpublished data.
  • Gonzatti-Haces, M., A. Seth, M. Park, T. Copeland, S. Oroszlan, and G. F. Vande Woude. 1988. Characterization of the TPR-MET oncogene p65 and the MET protooncogene pl40 protein-tyrosine kinases. Proc. Natl. Acad. Sci. USA 85:21-25.
  • Honegger, A. M., A. Schmidt, A. Ullrich, and J. Schlessinger. 1990. Separate endocytic pathways of kinase-defective and -active EGF-receptor mutants expressed in the same cells. J. Cell Biol. 110:1541-1548.
  • Hunter, T. 1987. A thousand and one protein kinases. Cell 50:823-829.
  • Hunter, T., and B. M. Sefton. 1980. Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc. Natl. Acad. Sci. USA 77:1311-1315.
  • Johnson, D. E., P. L. Lee, J. Lu, and L. T. Williams. 1990. Diverse forms of a receptor for acidic and basic fibroblast growth factors. Mol. Cell. Biol. 10:4728-4736.
  • Kashles, O., Y. Yarden, R. Fisher, A. Ullrich, and J. Schlessinger. 1991. A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization. Mol. Cell. Biol. 11:1454-1463.
  • Klein, R., D. Conway, L. Parada, and M. Barbacid. 1990. The trkB tyrosine protein kinase gene codes for a second neurogenic receptor that lacks the catalytic kinase domain. Cell 61:647-656.
  • Kohno, T., M. T. Brewer, S. L. Baker, P. E. Schwartz, M. W. King, K. K. Hale, C. H. Squires, R. C. Thompson, and J. L. Vannice. 1990. A second tumor necrosis factor receptor gene product can be shed a naturally occurring tumor necrosis factor inhibitor. Proc. Natl. Acad. Sci. USA 87:8331-8335.
  • Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685.
  • MacDonald, R. G., M. A. Tepper, K. B. Clairmont, S. B. Perregaux, and M. P. Czech. 1989. Serum form of the rat insulin-like growth factor II/mannose 6-phosphate receptor is truncated in the carboxyl-terminal domain. J. Biol. Chem. 264:3256-3261.
  • Middlemas, D. S., R. A. Lindberg, and T. Hunter. 1991. trkB, a neural receptor protein-tyrosine kinase: evidence for a full-length and two truncated receptors. Mol. Cell. Biol. 11:143-153.
  • Mosley, B., M. P. Beckmann, C. J. March, R. L. Idzerda, S. D. Gimpel, T. VandenBos, D. Friend, A. Alpert, D. Anderson, D. Jackson, J. M. Wignall, C. Smith, B. Gallis, J. E. Sims, D. Urdal, M. B. Widmer, D. Cosman, and L. S. Park. 1989. The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell 59:335-348.
  • Naldini, L., E. Vigna, R. Ferracini, P. Longati, L. Gandino, M. Prat, and P. M. Comoglio. 1991. The tyrosine kinase encoded by the met protooncogene is activated by autophosphorylation. Mol. Cell. Biol. 11:1793-1803.
  • Naldini, L., E. Vigna, R. P. Narsimhan, G. Gaudino, R. Zarnegar, G. K. Michalopoulos, and P. M. Comoglio. 1991. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. Oncogene 6:501-504.
  • Naldini, L., K. M. Weidner, E. Vigna, G. Gaudino, A. Bardelli, C. Ponzetto, R. P. Narsimhan, G. Hartmann, R. Zarnegar, G. Michalopoulos, W. Birchmeier, and P. M. Comoglio. 1991. Scatter factor and hepatocyte growth factor are indistinguishable ligands for the Met receptor? EMBO J. 10:2867-2878.
  • Novick, D., H. Engelmann, D. Wallach, and M. Rubinstein. 1989. Soluble cytokine receptors are present in normal human urine. J. Exp. Med. 170:1409-1414.
  • Park, M., M. Dean, C. S. Cooper, M. Schmidt, S. J. O’Brian, D. G. Blair, and G. F. Vande Woude. 1986. Mechanism of met oncogene activation. Cell 45:895-904.
  • Park, M., M. Dean, K. Kaul, M. J. Braun, M. A. Gonda, and G. Vande Woude. 1987. Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc. Natl. Acad. Sci. USA 84:6379-6383.
  • Ponzetto, C., S. Giordano, F. Peverali, G. Delia Valle, M. Abate, G. Vaula, and P. M. Comoglio. 1991. c-MET is amplified but not mutated in a cell line with an activated MET tyrosine kinase. Oncogene 6:553-559.
  • Prat, M., E. Medico, P. Piantino, S. Bretti, F. P. Rossini, and P. M. Comoglio. 1988. The monoclonal antibody-defined CAR-3 antigen is a serological marker associated with pancreatic carcinoma. Int. J. Biol. Markers 3:29-35.
  • Prat, M., R. P. Narsimhan, T. Crepaldi, M. R. Nicotra, P. G. Natali, and P. M. Comoglio. The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, in epithelial cells and in solid tumors. Int. J. Cancer, in press.
  • Prat, M., P. Rossino, G. Bussolati, I. Morra, and P. M. Comoglio. 1987. Production of monoclonal antibodies for the immu-nohistochemical detection of gastric carcinomas. Cancer Detect. Prevent. 10:293-301.
  • Prat, M. et al. Unpublished data.
  • Robb, R. J., and R. M. Kutny. 1987. Structure-function relationships for the IL 2-receptor system. IV. Analysis of the sequence and ligand-binding properties of soluble Tac protein. J. Immunol. 139:855-862.
  • Shih, Y. J., R. D. Baynes, B. G. Hudson, C. H. Flowers, B. S. Skikne, and J. D. Cook. 1990. Serum transferrin receptor is a truncated form of tissue receptor. J. Biol. Chem. 265:19077-19081.
  • Tempest, P. R., C. S. Cooper, and G. N. Major. 1986. The activated human met gene encodes a protein tyrosine kinase? FEBS Lett. 209:357-361.
  • Tempest, P. R., M. R. Stratton, and C. S. Cooper. 1988. Structure of the met protein and variation of met protein kinase activity among human tumour cell lines. Br. J. Cancer 58:3-7.
  • Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4353.
  • Ueno, H., H. Colbert, J. A. Escobedo, and L. T. Williams. 1991. Inhibition of PDGF β receptor signal transduction by coexpression of a truncated receptor. Science 252:844-848.
  • Ullrich, Α., and J. Schlessinger. 1990. Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212.
  • Weber, W., and G. N. Gill. 1984. Production of an epidermal growth factor receptor-related protein. Science 224:294-297.
  • Yarden, Y., and A. Ullrich. 1988. Growth factor receptor tyrosine kinases. Annu. Rev. Biochem. 57:443-478.
  • Zabrescky, J. R., T. Lam, S. J. McKenzie, and W. Carney. 1991. The extracellular domain of p185/neu is released from the surface of human breast carcinoma cells, SK-BR-3. J. Biol. Chem. 266:1716-1720.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.